Thirty-nine patients with acute enteric fever received the fixed-dose oral combination of pivmecillinam/pivampicillin. Thirty-seven (95%) subjects responded satisfactorily. No relapses or persistent faecal excretion of salmonellae were seen in the 29 patients followed up for 2 to 19 weeks. The treatment was well tolerated, no side-effects being recorded. In vitro studies revealed a synergistic interaction between mecillinam and ampicillin against isolates of Salmonella paratyphi A. © 1984 MMV Medizin Verlag GmbH München.
CITATION STYLE
Tanphaichitra, D., Srimuang, S., Chiaprasittigul, P., Menday, P., & Christensen, O. E. (1984). The combination of pivmecillinam and pivampicillin in the treatment of enteric fever. Infection, 12(6), 381–383. https://doi.org/10.1007/BF01645219
Mendeley helps you to discover research relevant for your work.